South Africa
08045134161
+919730316395

Order Today Lorbriqua (Lorlatinib) 100 mg Tablets Online at Best Price USA - New York, Cambridge

Lorbriqua (Lorlatinib) 100 mg Tablets Introduction Lorbriqua (Lorlatinib) 100 mg Tablets is a targeted anti-cancer medication used primarily in the treatment of advanced lung cancer. It belongs to a class of drugs known as ALK (Anaplastic Lymphoma Kinase) inhibitors, which are designed to block specific proteins responsible for cancer growth. This medicine is widely prescribed for patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), especially those who have developed resistance to earlier treatments. Composition and Content Active Ingredient: Lorlatinib 100 mg Drug Class: Tyrosine Kinase Inhibitor (TKI) Form: Oral Tablets Lorlatinib works by targeting abnormal ALK and ROS1 proteins that promote tumor growth, effectively slowing or stopping cancer progression. Contact Details 💬 WhatsApp: +91 9730316395 📞 Phone: +91 9730316395 📧 Email: info@globmedindia.com 🌐 Website: https://globmedindia.com How to Use Take the tablet orally with or without food. Swallow whole with water; do not crush or chew. Take at the same time every day for best results. Follow your oncologist’s instructions strictly. Dosage Standard Dose: 100 mg once daily Dose adjustments may be required based on: Side effects Liver function Drug interactions ⚠️ Always consult a healthcare professional before changing dosage. Uses Lorbriqua (Lorlatinib) is used for: Treatment of ALK-positive non-small cell lung cancer (NSCLC) Patients who: Have progressed after prior ALK inhibitor therapy Show resistance to earlier treatments Treatment Benefits Targets cancer at a molecular level Effective in brain metastases (crosses blood-brain barrier) Suitable for patients with treatment-resistant lung cancer Improves progression-free survival Advantages Highly specific targeted therapy Oral administration (no hospitalization needed) Effective against advanced-stage cancers Better management of tumor spread to brain Possible Side Effects Increased cholesterol or triglycerides Swelling (edema) Mood changes or cognitive effects Fatigue Weight gain ⚠️ Regular monitoring and blood tests are recommended. Storage Conditions Store at room temperature (20°C to 25°C) Keep away from moisture and direct sunlight Keep out of reach of children Alternative Indian Brands of Lorlatinib Some alternative brands available in India include: Lorlatinib Tablets by Natco Pharma Lorlatinib by Dr. Reddy’s Laboratories Lorlatinib by Hetero Healthcare Lorlatinib by Zydus Cadila These brands offer cost-effective options with similar efficacy. Buy Lorbriqua (Lorlatinib) 100 mg Tablets Online at Best Price Looking to buy Lorbriqua Lorlatinib 100 mg Tablets online? GlobMedIndia is a trusted medicine exporter from India, offering genuine and high-quality anti-cancer medicines at competitive prices. We specialize in global supply of oncology medicines, ensuring safe and timely delivery to countries including: Saudi Arabia: Riyadh, Jeddah, Mecca, Medina, Dammam United States & United Kingdom: Cambridge, London UAE & Middle East: Dubai, Abu Dhabi Europe, Australia, Africa & Southeast Asia Countries: Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, South Korea, Thailand, Vietnam Why Choose GlobMedIndia? ✔ 100% Genuine Medicines ✔ WHO-GMP Certified Suppliers ✔ Competitive Export Prices ✔ Fast & सुरक्षित International Delivery ✔ Expert Support for Bulk Orders Order Lorbriqua (Lorlatinib) Tablets Today GlobMedIndia ensures hassle-free ordering and doorstep delivery worldwide, making life-saving cancer treatments accessible globally. Conclusion Lorbriqua (Lorlatinib) 100 mg Tablets is a breakthrough therapy for patients suffering from ALK-positive lung cancer, especially in advanced stages. With its targeted mechanism and effectiveness against resistant cancer cells, it significantly improves patient outcomes. GlobMedIndia stands as a reliable partner in delivering high-quality anti-cancer medicines globally, ensuring accessibility, affordability, and trust.
 2026-04-01T10:27:02

Keywords